These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23593218)

  • 1. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome.
    Yeh E; Fanganiello RD; Sunaga DY; Zhou X; Holmes G; Rocha KM; Alonso N; Matushita H; Wang Y; Jabs EW; Passos-Bueno MR
    PLoS One; 2013; 8(4):e60439. PubMed ID: 23593218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly activated Wnt/β-catenin pathway co-receptors LRP5 and LRP6 regulate osteoblast differentiation in the developing coronal sutures of an Apert syndrome (Fgfr2
    Min Swe NM; Kobayashi Y; Kamimoto H; Moriyama K
    Dev Dyn; 2021 Mar; 250(3):465-476. PubMed ID: 32822074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
    Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
    Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 MAPK pathway in the skull abnormalities of Apert syndrome Fgfr2(+P253R) mice.
    Wang Y; Sun M; Uhlhorn VL; Zhou X; Peter I; Martinez-Abadias N; Hill CA; Percival CJ; Richtsmeier JT; Huso DL; Jabs EW
    BMC Dev Biol; 2010 Feb; 10():22. PubMed ID: 20175913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.
    Yokota M; Kobayashi Y; Morita J; Suzuki H; Hashimoto Y; Sasaki Y; Akiyoshi K; Moriyama K
    PLoS One; 2014; 9(7):e101693. PubMed ID: 25003957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study of abnormal bone development in the Apert syndrome Fgfr2+/S252W mouse using a 3D hydrogel culture model.
    Yang F; Wang Y; Zhang Z; Hsu B; Jabs EW; Elisseeff JH
    Bone; 2008 Jul; 43(1):55-63. PubMed ID: 18407821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble form of FGFR2 with S252W partially prevents craniosynostosis of the apert mouse model.
    Morita J; Nakamura M; Kobayashi Y; Deng CX; Funato N; Moriyama K
    Dev Dyn; 2014 Apr; 243(4):560-7. PubMed ID: 24259495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
    Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
    J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR2 mutation confers a less drastic gain of function in mesenchymal stem cells than in fibroblasts.
    Yeh E; Atique R; Ishiy FA; Fanganiello RD; Alonso N; Matushita H; da Rocha KM; Passos-Bueno MR
    Stem Cell Rev Rep; 2012 Sep; 8(3):685-95. PubMed ID: 22048896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the closed suture in apert syndrome mouse models: evidence of primary effects of FGFR2 signaling on facial shape at birth.
    Martínez-Abadías N; Percival C; Aldridge K; Hill CA; Ryan T; Sirivunnabood S; Wang Y; Jabs EW; Richtsmeier JT
    Dev Dyn; 2010 Nov; 239(11):3058-71. PubMed ID: 20842696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
    Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
    J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome.
    Holmes G; Basilico C
    Dev Biol; 2012 Aug; 368(2):283-93. PubMed ID: 22664175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniofacial divergence by distinct prenatal growth patterns in Fgfr2 mutant mice.
    Motch Perrine SM; Cole TM; Martínez-Abadías N; Aldridge K; Jabs EW; Richtsmeier JT
    BMC Dev Biol; 2014 Feb; 14():8. PubMed ID: 24580805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
    Lilli C; Bellucci C; Baroni T; Aisa C; Carinci P; Scapoli L; Carinci F; Pezzetti F; Lumare E; Stabellini G; Bodo M
    Cytokine; 2007 Apr; 38(1):22-31. PubMed ID: 17537644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIN1 Attenuation Improves Midface Hypoplasia in a Mouse Model of Apert Syndrome.
    Kim B; Shin H; Kim W; Kim H; Cho Y; Yoon H; Baek J; Woo K; Lee Y; Ryoo H
    J Dent Res; 2020 Feb; 99(2):223-232. PubMed ID: 31869252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deformed Skull Morphology Is Caused by the Combined Effects of the Maldevelopment of Calvarias, Cranial Base and Brain in FGFR2-P253R Mice Mimicking Human Apert Syndrome.
    Luo F; Xie Y; Xu W; Huang J; Zhou S; Wang Z; Luo X; Liu M; Chen L; Du X
    Int J Biol Sci; 2017; 13(1):32-45. PubMed ID: 28123344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation.
    Chen P; Zhang L; Weng T; Zhang S; Sun S; Chang M; Li Y; Zhang B; Zhang L
    PLoS One; 2014; 9(1):e87311. PubMed ID: 24489893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells.
    Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M
    Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fgfr2(S252W/+) mutation in mice retards mandible formation and reduces bone mass as in human Apert syndrome.
    Zhou X; Pu D; Liu R; Li X; Wen X; Zhang L; Chen L; Deng M; Liu L
    Am J Med Genet A; 2013 May; 161A(5):983-92. PubMed ID: 23495007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF/FGFR signaling coordinates skull development by modulating magnitude of morphological integration: evidence from Apert syndrome mouse models.
    Martínez-Abadías N; Heuzé Y; Wang Y; Jabs EW; Aldridge K; Richtsmeier JT
    PLoS One; 2011; 6(10):e26425. PubMed ID: 22053191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.